The AMGA Foundation's initiative focuses on secondary prevention of ASCVD using a population health approach to improve patient care and outcomes. The framework provides evidence-based strategies for ...

The American College of Cardiology (ACC) has released an Expert Consensus Decision Pathway (ECDP) to provide guidance on treating and managing patients with atherosclerotic cardiovascular disease ...

Fenofibrate as an adjunct to statins was associated with lower risks for all-cause mortality and cardiovascular disease among individuals with type 2 diabetes. Fenofibrate as an adjunct to statin ...

New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

Share on Pinterest A study found that a large number of patients do not receive recommended treatment for atherosclerotic cardiac disease (ASCVD). Denis Kirichkov/Stocksy In 2013, new guidelines were ...

Please provide your email address to receive an email when new articles are posted on . Risk for major adverse CV events was similar for adults receiving tirzepatide vs. dulaglutide. All-cause ...

BACKGROUND: Discrimination in health care can influence patient behavior and potentially lead to poor quality care. When ...

Please provide your email address to receive an email when new articles are posted on . Atherosclerotic CVD was more prevalent among individuals of South Asian ancestry compared with those of European ...

No significant differences in efficacy or safety of 2 aspirin doses were found between male and female patients for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD). No ...